Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis

Breast J. 2020 Oct;26(10):2096-2098. doi: 10.1111/tbj.13870. Epub 2020 May 18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms* / therapy
  • Ethnicity
  • Female
  • Humans
  • Israel / epidemiology
  • Neoplasm Recurrence, Local
  • Receptor, ErbB-2
  • Receptors, Progesterone
  • Registries

Substances

  • Biomarkers, Tumor
  • Receptors, Progesterone
  • Receptor, ErbB-2

Grants and funding